
Doripenem
CAS No. 148016-81-3
Doripenem( —— )
Catalog No. M22509 CAS No. 148016-81-3
Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
![]() ![]() |
25MG | 77 | In Stock |
![]() ![]() |
50MG | 115 | In Stock |
![]() ![]() |
100MG | 173 | In Stock |
![]() ![]() |
200MG | 258 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDoripenem
-
NoteResearch use only, not for human use.
-
Brief DescriptionDoripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
-
DescriptionDoripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorantibiotic
-
Research Areainfection;Urinary system;Respiratory system
-
IndicationInfection|Cross Infection|Bacterial Infections|Pneumonia, Ventilator-Associated|Intra-abdominal Infections|Urinary Tract Infections
Chemical Information
-
CAS Number148016-81-3
-
Formula Weight420.5
-
Molecular FormulaC15H24N4O6S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wagenlehner, Florian, M, et al. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program[J]. Clinical Infectious Diseases, 2016.
molnova catalog



related products
-
Ceforanide
Ceforanide is a second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall.
-
GSK 951A
A small molecule with bactericidal efficacy against Mycobacterium tuberculosis with H37Rv MIC of 0.16 uM.
-
Radezolid
Radezolid is a novel oxazolidinone antibiotic agent.